Novo Nordisk A/S NVO
Set alert
40.35 USD -0.11 -0.26%
As of Nov 3, 1:34 PM ET
40.17 Day range 40.63
35.12 52-week range 64.16
- YTD
- -20.71%
- 1 year
- -17.85%
- Open
- 40.34
- Prev close
- 40.45
- Mkt cap
- 177.95B
- Vol
- 5.05M
- Avg vol
- 12.68M
- EPS
- 4.09
- P/E
- 9.86
- Div yield
- 2.08%
More statistics
- Low
- 40.17
- High
- 40.63
- Forward P/E
- 11.76
- Beta
- 0.37
- Short ratio
- 2.52
- Inst. own
- 9.83%
- Dividend
- 1.80
- Ex-div date
- Aug 16, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 41.23
- 200-d avg
- 44.19
- 1y target
- 45.09
5D chart
Signals (85)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 3, 1:30 PM | 4 minutes ago |
| MACD: Buy Signal | Nov 3, 1:30 PM | 4 minutes ago |
| MACD: Sell Signal | Nov 3, 12:15 PM | 1 hour ago |
| SMA: Bearish | Nov 3, 12:10 PM | 1 hour ago |
| SMA: Bearish | Nov 3, 12:10 PM | 1 hour ago |
| MACD: Buy Signal | Nov 3, 11:55 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 11:50 AM | 1 hour ago |
| MACD: Sell Signal | Nov 3, 11:20 AM | 2 hours ago |
| SMA: Bullish | Nov 3, 11:05 AM | 2 hours ago |
| SMA: Bearish | Nov 3, 11:00 AM | 2 hours ago |
| SMA: Bearish | Nov 3, 11:00 AM | 2 hours ago |
| SMA: Bullish | Nov 3, 10:30 AM | 3 hours ago |
| SMA: Bearish | Nov 3, 10:20 AM | 3 hours ago |
| SMA: Bullish | Nov 3, 10:10 AM | 3 hours ago |
| MACD: Buy Signal | Nov 3, 10:00 AM | 3 hours ago |
| RSI: Oversold | Nov 3, 9:30 AM | 4 hours ago |
| MACD: Sell Signal | Nov 2, 3:45 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 3:20 PM | 22 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 22 hours ago |
Newest 20 of 85.
Analyst view
Consensus: hold
Hold
Price target (mean) 45.09 +11.8% upside
Now 40.35
- Target (low)
- 39.75
- Target (mean)
- 45.09
- Target (high)
- 61.79
Ratings (0m) 14 3 buy · 10 hold · 1 sell
- Strong buy0
- Buy3
- Hold10
- Sell1
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 4.62 | 4.01 – 5.28 | 4.50 | +2.7% | 73.79B | -1.6% | 3 |
| Next quarter | 4.31 | 4.26 – 4.36 | 6.04 | -28.7% | 76.23B | -3.7% | 2 |
| Current year | 22.39 | 21.01 – 24.25 | 23.03 | -2.8% | 303.54B | -1.8% | 8 |
| Next year | 22.89 | 21.73 – 23.74 | 22.39 | +2.3% | 307.63B | +1.4% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Sep 11, 2026 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Mar 2, 2026 | Goldman Sachs | Downgrade | Buy | Neutral |
| Feb 24, 2026 | JP Morgan | Downgrade | Overweight | Neutral |
| Jan 9, 2026 | CICC | Initiated | — | Outperform |
| Dec 8, 2025 | Argus Research | Downgrade | Buy | Hold |
| Nov 28, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Nov 25, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Nov 24, 2025 | HSBC | Downgrade | Buy | Hold |
| Oct 14, 2025 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 2, 2025 | HSBC | Upgrade | Hold | Buy |
| Sep 29, 2025 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Sep 17, 2025 | Berenberg | Upgrade | Hold | Buy |
| Aug 19, 2025 | TD Cowen | Maintained | Buy | Buy |
| Aug 5, 2025 | UBS | Downgrade | Buy | Neutral |
| Jul 31, 2025 | HSBC | Downgrade | Buy | Hold |
| Jul 30, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jun 18, 2025 | TD Cowen | Reiterated | Buy | Buy |
| Apr 17, 2025 | BMO Capital | Downgrade | Outperform | Market Perform |
| Jan 8, 2025 | UBS | Upgrade | Sell | Buy |
| Dec 23, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Nov 6, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 22, 2024 | Citigroup | Maintained | Buy | Buy |
| Oct 17, 2024 | BMO Capital | Maintained | Outperform | Outperform |
| Oct 16, 2024 | Barclays | Maintained | Overweight | Overweight |
| Oct 14, 2024 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 10, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Oct 10, 2024 | Jefferies | Initiated | — | Buy |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 16, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
